The first drug for the treatment of Alzheimer’s disease is approved in the United States
The US Food and Drug Administration (FDA) has authorized the use of Leqembi, a drug designed to slow the progression of Alzheimer’s disease. It is noted that this is the only drug of its kind approved by the FDA. Leqembi uses antibodies that target amyloid beta. This protein plays an important role in the development […]